You are here

  • Home
  • Archive
  • Volume 13, Issue 1
  • Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study

Article info

Article menu
HIV/AIDS
Protocol
Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study

Authors

  • Léna Royston Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, CanadaCanadian HIV Trials Network, Canadian Institutes of Health Research, Vancouver, BC, CanadaDivision of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Stéphane Isnard Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, CanadaCanadian HIV Trials Network, Canadian Institutes of Health Research, Vancouver, BC, Canada PubMed articlesGoogle scholar articles
  • Carolina A. Berini Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, CanadaCONICET, Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Buenos Aires, Argentina PubMed articlesGoogle scholar articles
  • Simeng Bu Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  • Peter L. Lakatos Division of Gastroenterology, McGill University Health Centre, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  • Talat Bessissow Division of Gastroenterology, McGill University Health Centre, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  • Nicolas Chomont Department de Microbiologie, Maladies Infectieuses et Immunologie, Centre de Recherche du Centre Hospitalier de l'Université de Montreal, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  • Marina Klein Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, CanadaCanadian HIV Trials Network, Canadian Institutes of Health Research, Vancouver, BC, Canada PubMed articlesGoogle scholar articles
  • Bertrand Lebouché Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, CanadaCentre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaDepartment of Family Medicine, McGill University Health Centre, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  • Alexandra de Pokomandy Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, CanadaDepartment of Family Medicine, McGill University Health Centre, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  • Nadine Kronfli Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  • Cecilia T. Costiniuk Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, CanadaCanadian HIV Trials Network, Canadian Institutes of Health Research, Vancouver, BC, Canada PubMed articlesGoogle scholar articles
  • Rejean Thomas Clinique Médicale L'Actuel, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  • Cécile Tremblay Department de Microbiologie, Maladies Infectieuses et Immunologie, Centre de Recherche du Centre Hospitalier de l'Université de Montreal, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  • Guy Boivin Division of Pediatrics, Faculty of Medicine, Laval University, Quebec city, QC, Canada PubMed articlesGoogle scholar articles
  • Jean-Pierre Routy Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, CanadaChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, CanadaDivision of Hematology, McGill University Health Centre, Montreal, QC, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jean-Pierre Routy; jean-pierre.routy{at}mcgill.ca; Dr Léna Royston; lena.royston{at}mail.mcgill.ca
View Full Text

Citation

Royston L, Isnard S, Berini CA, et al
Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study
BMJ Open 2023;13:e067640. doi: 10.1136/bmjopen-2022-067640

Publication history

  • Received August 23, 2022
  • Accepted December 8, 2022
  • First published January 23, 2023.
Online issue publication 
October 24, 2023
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.